Photo

613-567-0762

...

Ottawa

English

Tanya Weston

Associate

Tanya Weston’s practice focuses mainly on patent and regulatory matters related to pharmaceutical, biotechnology and medical device patents and applications. Tanya is a co-founding member of the firm’s Regulatory Working Group and regularly advises clients on issues relating to regulatory approval, market exclusivity and the pricing and reimbursement of pharmaceuticals and biologics.

Tanya is a regular guest lecturer at the University of Ottawa, Faculty of Common Law, on issues related to the Patented Medicine Prices Review Board, Canada’s Access to Medicines Regime and the listing and interchangeability of drug products at the provincial and territorial level as part of a larger course on intellectual property law as it relates to biotechnology and pharmaceuticals.

Prior to joining MBM, Tanya worked at Health Canada in various regulatory roles related to the application, enforcement and amendment of the Food & Drug Regulations. Tanya also worked at a pharmaceutical research unit in the United Kingdom, where she conducted drug safety and efficacy studies.

Tanya is a Registered Canadian Trade-mark Agent.

Education

  • B.Sc., Nutritional Sciences, Mount Saint Vincent
  • M.Sc., Community Health and Epidemiology, Queen’s University
  • LL.B., University of Ottawa

Professional Involvement

 Law Society of Upper Canada (Ontario) 

Technology Area

Dr. Poonam Tauh

DR. POONAM TAUH

Patent Agent


Poonam’s focuses on the drafting and prosecution of pharmaceutical, chemical, biochemical, petrochemical, and polymer patent applications around the world.
MBM read_more_btn

MBM logo

About MBM

The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

No Excuses. Canada Must Deliver New Copyright Legislation To The International Community

Now that Stephen Harper has achieved majority with an unexpected May 2nd win, there is no reason why the long awaited amendments to Canada’s Copyright legislation should not be passed into law...
Read More